Dec 19 (Reuters) - The U.S. Food and Drug Administration said on Friday it has authorized the marketing of six Altria-owned on! PLUS nicotine pouch products, through a pilot program aimed to fast-track reviews of such products.
The authorization was the first under the pilot program that the FDA launched in September, and applies to six on! PLUS nicotine pouches, which are manufactured by Helix Innovations LLC, an Altria joint venture for the global on! PLUS nicotine pouch portfolio.
The company had applied for premarket authorization for the products in June 2024.
The decision allows the mint, tobacco and wintergreen-flavored pouches, offered in 6 mg and 9 mg nicotine strengths, to be legally sold to adults in the United States.
The FDA said its decision was based on evidence that the products contain lower levels of harmful chemicals, posing a lower risk of cancer and other serious health conditions compared to other smokeless tobacco products. The authorization applies only to the specified products and not to other Helix offerings.
Nicotine pouches, which users insert under the lip, are the fastest-growing category of tobacco products in the U.S., and are generally considered among the lowest-risk smoking alternatives given they do not involve inhalation and do not contain tobacco.
Earlier this year, 20 Zyn products, owned by Philip Morris became the first in the nicotine pouch category to receive market authorization from the FDA in the U.S.
Zyn products were approved in January, more than five years after the company first submitted its application.
Tobacco companies have invested heavily in developing and marketing alternatives to cigarettes as demand for these products grows.
"on! PLUS will resume taking new orders for retail accounts in Florida, North Carolina and Texas and on e-commerce soon," Altria said to Reuters.
Nicotine in adolescence can harm the parts of the brain that control attention, learning, mood and impulse control, according to the U.S. Centers for Disease Control and Prevention.
(Reporting by Sanskriti Shekhar and Juveria Tabassum in Bengaluru; Editing by Alan Barona)
LATEST POSTS
- 1
6 Famous Cell phone Brands All over The Planet - 2How a niche Catholic approach to infertility treatment became a new talking point for MAHA conservatives
- 3Paraplegic engineer becomes the first wheelchair user to blast into space
- 4NASA begins the countdown for humanity's first launch to the moon in 53 years
- 5How Much Has the Iran War Cost the Average American Per Day?
- Best Veggie lover Dinner: What's Your Plant-Based Pick?
- Early Thanksgiving week forecast: Where Americans can expect cold, rain and snow for the holiday
- 5 Destinations Where Airfare Is Dropping The Most For Spring 2026, Per Dollar Flight Club Analysis
- Brexit's Effect on New York's Ascent as a Main Monetary Center
- Select Your Cherished Fish
- When Would it be a good idea for you to Look for Help from a Criminal Legal counselor?
- 21 Incredibly Interesting Contemplations To Observe Consistently
- Indian Health Service is digging out of decades-old construction backlog for medical buildings
- 6 Asian Urban areas to Visit
